TABLE 8.
Explanatory variable | IL-2+ SFC |
IFN-γ+ SFC |
IFN-γ+ IL-2+ SFC |
|||
---|---|---|---|---|---|---|
RCE | P | RCE | P | RCE | P | |
Age | −2.46 | 0.04 | −1.45 | 0.14 | −1.83 | 0.02 |
Baseline value | 0.27 | 0.07 | 0.72 | <0.001 | 0.39 | 0.01 |
Peak value | 0.46 | <0.001 | 0.10 | 0.15 | 0.35 | <0.001 |
VZV CD4+ CD39+ | −28.85 | 0.33 | −47.73 | 0.11 | −26.63 | 0.20 |
VZV CD8+ CD39+ | −1.36 | 0.94 | 12.98 | 0.43 | −2.02 | 0.86 |
VZV CD4+ FOXP3+ | 7.74 | 0.86 | 36.91 | 0.38 | 7.44 | 0.81 |
VZV CD8+ FOXP3+ | 12.18 | 0.59 | 7 | 0.75 | 10.36 | 0.51 |
VZV CD4+ IL-10+ | 16.61 | 0.73 | 44.86 | 0.35 | 0.41 | 0.99 |
VZV CD8+ IL-10+ | −50.42 | 0.15 | −42.25 | 0.23 | −24.24 | 0.33 |
VZV CD4+ TGF-β+ | 8.93 | 0.68 | −10.27 | 0.63 | −0.51 | 0.97 |
VZV CD8+ TGF-β+ | 4.41 | 0.7 | 6.16 | 0.59 | 4.39 | 0.59 |
Boldface type indicates statistically significant effects. Abbreviations: VZV, varicella-zoster virus; Th1, T helper 1; RCE, regression coefficient estimate (indicates the magnitude of the effect of the explanatory variable on the outcome measure); SFC, spot-forming cells/106 PBMC; baseline responses, prevaccination responses in the same category as the outcome measure (e.g., prevaccination IFN-γ SFC as an explanatory variable for peak IFN-γ SFC or prevaccination IL-2 SFC as an explanatory variable for peak IL-2 SFC, etc.).